OCULUS INC. financial data

Symbol
OVTZ on OTC
Location
Vancouver
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Return On Equity 64% % -60%
Return On Assets -1038% % -182%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 91,422,569 shares 0%
Common Stock, Shares, Outstanding 91,422,569 shares 0%
Entity Public Float $4,000,000 USD 0%
Common Stock, Value, Issued $46,850,710 USD 0%
Weighted Average Number of Shares Outstanding, Basic 91,422,569 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $1,476 USD -83%
General and Administrative Expense $111,184 USD 73%
Costs and Expenses $343,290 USD 3.4%
Net Income (Loss) Attributable to Parent $343,181 USD -4.8%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $15,229 USD 337%
Assets $25,240 USD 52%
Liabilities, Current $692,476 USD 108%
Accumulated Other Comprehensive Income (Loss), Net of Tax $31,177 USD 5.1%
Retained Earnings (Accumulated Deficit) $48,961,757 USD -0.71%
Stockholders' Equity Attributable to Parent $667,236 USD -111%
Liabilities and Equity $25,240 USD 52%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,286 USD 95%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 91,422,569 shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,624 USD 94%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $7,113,000 USD -0.5%
Deferred Tax Assets, Gross $7,113,000 USD -0.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $350,499 USD -8%
Deferred Tax Assets, Operating Loss Carryforwards $6,934,000 USD -0.03%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 250,000,000 shares 0%
Additional Paid in Capital $1,485,000 USD 0%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares